PROVIDER PROFILE · NPI 1609877190

Tanya SchreibmanM.D.

PRACTICECAN COMMUNITY HEALTH, INC.See all providers at this practice →

Infectious DiseaseSarasota, FLI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

137

Unique beneficiaries

—

Total services

293

Distinct HCPCS

Medicare payment

$14K

Peer benchmark

Total Medicare services vs. 502 Infectious Disease providers in FL — bottom quintile (cohort median 1,070).

PRESCRIBING · PART D · 2024

Total Rx claims

5,944

Beneficiaries

—

Total drug cost

$7.3M

Distinct drugs

Brand share

49.7%

Top prescribed drugs

Bictegrav/Emtricit/Tenofov Ala616 claims

Rosuvastatin Calcium368 claims

Amlodipine Besylate338 claims

Dolutegravir Sodium/Lamivudine337 claims

Elviteg/Cob/Emtri/Tenof Alafen210 claims

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

90.0

Cost

67.7

Improvement activities

40.0

Promoting interop.

96.0

Payment adjustment

1.05%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$599

Payment records

By payment type

Food and Beverage$599

REFERRAL NETWORK

Where Tanya Schreibman's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
SARASOTA COUNTY PUBLIC HOSPITAL DISTRICT	30	143
Laboratory Corporation Of America Clinical Laboratory · Tampa, FL	22	51
Matthew Thomas Psychiatry · Sarasota, FL	11	46

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history